US3172546A
(en)
|
1961-05-19 |
1965-03-09 |
Union Carbide Corp |
Size reduction of biological substances
|
US4133814A
(en)
|
1975-10-28 |
1979-01-09 |
Eli Lilly And Company |
2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
|
US4200631A
(en)
*
|
1975-12-17 |
1980-04-29 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Treating mammalian subject sensitive to indomethacin ulcerogenisis
|
IT1082518B
(it)
|
1977-01-25 |
1985-05-21 |
Fiat Spa |
Specchio a cristallo liquido da impiegare particolarmente come retrovisore per veicoli
|
NL175882C
(nl)
*
|
1977-03-28 |
|
Procter & Gamble |
Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
US4380635A
(en)
|
1981-04-03 |
1983-04-19 |
Eli Lilly And Company |
Synthesis of acylated benzothiophenes
|
DK150008C
(da)
*
|
1981-11-20 |
1987-05-25 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
|
DE3312671A1
(de)
|
1983-04-08 |
1984-10-11 |
Heinz Finzer KG, 7880 Bad Säckingen |
Stanz- und biegewerkzeug-aggregat
|
GB8403359D0
(en)
*
|
1984-02-08 |
1984-03-14 |
Erba Farmitalia |
Pharmaceutical compositions
|
US4851228A
(en)
*
|
1984-06-20 |
1989-07-25 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic
|
IT1227626B
(it)
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
JP2642486B2
(ja)
|
1989-08-04 |
1997-08-20 |
田辺製薬株式会社 |
難溶性薬物の超微粒子化法
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
AU660852B2
(en)
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
US5298262A
(en)
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
US5336507A
(en)
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
ZA951497B
(en)
|
1994-03-02 |
1996-08-23 |
Lilly Co Eli |
Orally administerable pharmaceutical formulations
|
US5478705A
(en)
|
1994-05-25 |
1995-12-26 |
Eastman Kodak Company |
Milling a compound useful in imaging elements using polymeric milling media
|
US5500331A
(en)
|
1994-05-25 |
1996-03-19 |
Eastman Kodak Company |
Comminution with small particle milling media
|
US5631369A
(en)
|
1994-08-31 |
1997-05-20 |
Eli Lilly And Company |
Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
US5591456A
(en)
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
TW487582B
(en)
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
US6458811B1
(en)
|
1996-03-26 |
2002-10-01 |
Eli Lilly And Company |
Benzothiophenes formulations containing same and methods
|
US6713494B1
(en)
|
1996-08-28 |
2004-03-30 |
Eli Lilly And Company |
Amorphous benzothiophenes, methods of preparation and methods of use
|
WO1998035666A1
(en)
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
JP4117811B2
(ja)
*
|
1997-04-22 |
2008-07-16 |
日本化薬株式会社 |
フルタミド製剤及びその製法
|
ZA987800B
(en)
|
1997-08-27 |
1999-06-09 |
Hexal Ag |
Pharmaceutical composition of meloxicam
|
JPH11130698A
(ja)
*
|
1997-10-31 |
1999-05-18 |
Freunt Ind Co Ltd |
アルギン酸多価金属塩球状微粒子集合体、該球状微粒子集合体に難溶性薬剤を担持した放出制御製剤及びそれらの製造方法
|
US6165506A
(en)
|
1998-09-04 |
2000-12-26 |
Elan Pharma International Ltd. |
Solid dose form of nanoparticulate naproxen
|
JP2000095674A
(ja)
|
1998-09-22 |
2000-04-04 |
Sato Pharmaceutical Co Ltd |
口腔内崩壊時間短縮化錠剤の製造方法及び装置
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20040013613A1
(en)
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
EP1066825A1
(en)
|
1999-06-17 |
2001-01-10 |
The Procter & Gamble Company |
An anti-microbial body care product
|
DE19932157A1
(de)
|
1999-07-13 |
2001-01-18 |
Pharmasol Gmbh |
Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
CN100551358C
(zh)
|
2000-06-27 |
2009-10-21 |
维克多瑞有限公司 |
用于药物组合物的颗粒的制备方法
|
ES2325057T3
(es)
|
2000-08-31 |
2009-08-25 |
Jagotec Ag |
Particulas molturadas.
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
EP1341521B1
(en)
|
2000-11-20 |
2009-01-07 |
Elan Pharma International Limited |
Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
DK1337240T4
(en)
|
2000-11-30 |
2015-01-05 |
Vectura Ltd |
A process for the preparation of particles for use in a pharmaceutical composition
|
WO2002045684A2
(en)
|
2000-12-06 |
2002-06-13 |
Pharmacia Corporation |
Rapidly dispersing pharmaceutical composition comprising effervescent agents
|
FI20010115A0
(fi)
|
2001-01-18 |
2001-01-18 |
Orion Corp |
Menetelmä nanopartikkelien valmistamiseksi
|
EP1401401B1
(en)
|
2001-06-22 |
2005-03-30 |
Marie Lindner |
Method for high through put screening using a small scale mill or microfluidics
|
JP2003066613A
(ja)
|
2001-08-22 |
2003-03-05 |
Columbia Music Entertainment Inc |
スタンパの製造方法
|
WO2003030872A2
(en)
|
2001-10-12 |
2003-04-17 |
Elan Pharma International Ltd. |
Compositions having a combination of particles for immediate release and for controlled release
|
US7714006B1
(en)
|
2001-12-03 |
2010-05-11 |
King Pharmaceuticals Research & Development, Inc. |
Methods of modifying the bioavailability of metaxalone
|
US6407128B1
(en)
|
2001-12-03 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Method for increasing the bioavailability of metaxalone
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US6825161B2
(en)
|
2002-04-26 |
2004-11-30 |
Salvona Llc |
Multi component controlled delivery system for soap bars
|
WO2004019937A1
(en)
|
2002-09-02 |
2004-03-11 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical composition of metaxalone with enhanced oral bioavailability
|
JP2004099442A
(ja)
*
|
2002-09-04 |
2004-04-02 |
Nisshin Pharma Inc |
難溶性薬物含有製剤およびその製造方法
|
CA2499819A1
(en)
|
2002-09-30 |
2004-04-08 |
A/S Gea Farmaceutisk Fabrik |
Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
|
AU2003297151A1
(en)
|
2002-12-17 |
2004-07-22 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
US20050163839A1
(en)
|
2003-01-29 |
2005-07-28 |
Sun Pharmaceutical Industries Limited |
Oral controlled release pharmaceutical composition containing metaxalone as active agent
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
US7749533B2
(en)
*
|
2003-05-07 |
2010-07-06 |
Akina, Inc. |
Highly plastic granules for making fast melting tablets
|
AU2003304242A1
(en)
*
|
2003-06-27 |
2005-01-13 |
Bioprogress S.P.A. |
Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate
|
US20050042177A1
(en)
|
2003-07-23 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel compositions of sildenafil free base
|
CA2534924A1
(en)
|
2003-08-08 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel metaxalone compositions
|
WO2005020933A2
(en)
|
2003-09-02 |
2005-03-10 |
University Of South Florida |
Nanoparticles for drug-delivery
|
WO2005032703A1
(fr)
|
2003-10-01 |
2005-04-14 |
Debio Recherche Pharmaceutique S.A. |
Dispositif et procede pour la fabrication de particules
|
EP1686962B9
(en)
|
2003-11-05 |
2012-10-03 |
Elan Pharma International Limited |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
ES2430849T3
(es)
|
2004-03-08 |
2013-11-22 |
Spiridon Spireas |
Formas de dosificación sólidas biodisponibles de metaxalona
|
CN101005828B
(zh)
|
2004-06-17 |
2012-01-11 |
维尔恩公司 |
用于经粘膜递送活性成分的包含粘膜粘附蛋白和所述活性物质的组合物
|
WO2006009419A1
(es)
|
2004-07-19 |
2006-01-26 |
Luis Cordova Boone |
Neumáticos con doble banda de rodamiento
|
KR20060024927A
(ko)
|
2004-09-15 |
2006-03-20 |
씨제이 주식회사 |
기계적 분쇄법에 의한 미크론 사이즈 인삼 분말의제조방법
|
WO2006041843A2
(en)
|
2004-10-04 |
2006-04-20 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical dosage form comprising meloxicam
|
CA2582767C
(en)
*
|
2004-10-25 |
2011-05-24 |
Japan Tobacco Inc. |
Solid formulation with improved solubility and stability and method for producing said formulation
|
CA2598204C
(en)
|
2004-11-09 |
2015-01-13 |
Board Of Regents, The University Of Texas System |
Stabilized hme composition with small drug particles
|
UA89513C2
(uk)
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
US20090028948A1
(en)
|
2004-12-31 |
2009-01-29 |
Iceutica Pty Ltd |
Nanoparticle composition and methods of synthesis thereof
|
MX2007014163A
(es)
|
2005-05-10 |
2008-01-24 |
Elan Pharma Int Ltd |
Formulaciones de nanoparticulas de clopidogrel.
|
JO3352B1
(ar)
|
2005-06-17 |
2019-03-13 |
Apr Applied Pharma Res Sa |
صيغ دايكلوفيناك وطرق استخدامه
|
US20080292584A1
(en)
|
2005-10-14 |
2008-11-27 |
Mutual Pharmaceutical Company, Inc. |
Metaxalone products, method of manufacture, and method of use
|
PT1973527E
(pt)
|
2005-12-15 |
2010-01-04 |
Acusphere Inc |
Processos de produção de formulações farmacêuticas à base de partículas destinadas a administração parentérica
|
WO2007070851A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
JP2009519970A
(ja)
*
|
2005-12-15 |
2009-05-21 |
アキュスフィア, インコーポレイテッド |
粒子ベースの経口投与用製薬剤形の製造方法
|
WO2007074477A2
(en)
|
2005-12-29 |
2007-07-05 |
Dabur Pharma Limited |
Metaxalone polymorphs
|
JP5543200B2
(ja)
|
2006-04-28 |
2014-07-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
3−(3−ジメチルアミノ−1−エチル−2−メチル−プロピル)−フェノール及びnsaid含む医薬の組合せ
|
US8420122B2
(en)
|
2006-04-28 |
2013-04-16 |
Merck Sharp & Dohme Corp. |
Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
|
AU2007260822B2
(en)
|
2006-06-23 |
2012-07-05 |
Alkermes Pharma Ireland Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
WO2008000042A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Iceutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
TWI645862B
(zh)
|
2006-06-30 |
2019-01-01 |
艾修提卡股份有限公司 |
包含奈米微粒形式生物活性化合物之劑型形式
|
CN100386312C
(zh)
|
2006-07-18 |
2008-05-07 |
上海世景国际贸易有限公司 |
2,4-二氨基苯磺酸及其盐的合成方法
|
US20100003332A1
(en)
|
2006-07-27 |
2010-01-07 |
Amorepacific Corporation |
Process For Preparing Powder Comprising Nanoparticles of Sparingly Soluble Drug
|
GB0625322D0
(en)
*
|
2006-12-19 |
2007-01-24 |
Pharmakodex Ltd |
Pharmaceutical compositions
|
AR065802A1
(es)
|
2007-03-22 |
2009-07-01 |
Schering Corp |
Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
|
TWI405590B
(zh)
*
|
2007-04-06 |
2013-08-21 |
Activus Pharma Co Ltd |
微粉碎化有機化合物粒子之製法
|
AR067997A1
(es)
|
2007-08-24 |
2009-10-28 |
Novartis Ag |
Compuestos organicos
|
US8568696B2
(en)
|
2008-08-06 |
2013-10-29 |
Indiana Nanotech Llc |
Grinding method for the manipulation or preservation of calcium phosphate hybrid properties
|
EA201171281A1
(ru)
|
2009-04-24 |
2012-05-30 |
Айсьютика Пти Лтд. |
Производство инкапсулированных наночастиц в коммерческих масшатабах
|
EP2421516A4
(en)
|
2009-04-24 |
2012-11-07 |
Iceutica Pty Ltd |
METHOD FOR ENHANCING THE DISSOLUTION PROFILE OF A BIOLOGICALLY ACTIVE MATERIAL
|
NZ595986A
(en)
|
2009-04-24 |
2014-04-30 |
Iceutica Pty Ltd |
A novel formulation of indomethacin
|
NZ595902A
(en)
|
2009-04-24 |
2014-10-31 |
Iceutica Pty Ltd |
Method for the production of commercial nanoparticle and microparticle powders
|
JP6116244B2
(ja)
|
2009-04-24 |
2017-04-19 |
イシューティカ ピーティーワイ リミテッド |
ナプロキセンの新規製剤
|
WO2010121324A1
(en)
|
2009-04-24 |
2010-10-28 |
Iceutica Pty Ltd |
A novel formulation of metaxalone
|
AP3138A
(en)
|
2009-04-24 |
2015-02-28 |
Iceutica Pty Ltd |
Production of encapsulated nanoparticles at high volume fractions
|
CN106420667A
(zh)
|
2009-04-24 |
2017-02-22 |
伊休蒂卡有限公司 |
双氯芬酸的新剂型
|
NZ722319A
(en)
|
2009-04-24 |
2018-01-26 |
Iceutica Pty Ltd |
A novel formulation of meloxicam
|
JP2011005735A
(ja)
|
2009-06-25 |
2011-01-13 |
Olympus Corp |
画像記録装置及び画像記録装置の初期化制御方法
|